Glioblastoma Clinical Trials 2024

Glioblastoma Clinical Trials 2024

Glioblastoma research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in gbm clinical trials today.

Glioblastoma Clinical Trials

Here are the 6 most popular medical studies for glioblastoma

Popular filter options for glioblastoma trials

Gliosarcoma Clinical Trials

View 32 Gliosarcoma medical studies.

Anaplastic Astrocytoma Clinical Trials

View 29 Anaplastic Astrocytoma medical studies.

Metastatic Glioblastoma Clinical Trials

View 99 metastatic glioblastoma medical studies.

MGMT Positive Clinical Trials

View 12 MGMT positive medical studies.

MET Positive Clinical Trials

View 8 MET positive medical studies.

Glioblastoma Clinical Trials With No Placebo

View 99 glioblastoma medical studies that do not have a placebo group.

View More Glioblastoma Trials

See another 68 medical studies focused on glioblastoma.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to glioblastoma

What are the top hospitals conducting glioblastoma research?

When it comes to pioneering clinical trials for glioblastoma, several top hospitals are making significant strides in this challenging field. In Boston, the Dana-Farber Cancer Institute leads the way with 11 active trials dedicated to tackling this aggressive brain cancer. With a remarkable history of 65 completed glioblastoma trials since their first recorded effort in 1998, they have been at the forefront of breakthrough research. Meanwhile, Memorial Sloan Kettering Cancer Center in New York is also making notable contributions with eight ongoing glioblastoma trials and an impressive track record of 47 previous studies dating back to their initial trial in 2002.

Moving westward to Saint Louis, the Washington University School of Medicine has emerged as another key player in glioblastoma research. With eight active clinical trials and a history of 49 past investigations since their first recorded trial in 2006, they are pushing boundaries and seeking innovative solutions for this devastating disease. Closer to home on the East Coast, Lenox Hill Brain tumor Center in New York boasts five ongoing clinical trials focused on glioblastoma along with a total of fifteen previously conducted studies since their groundbreaking trial's initiation back in 2006.

Finally arriving on the West Coast at San Francisco's esteemed University of California site; here too researchers are dedicating efforts towards confronting this complex brain tumor type through five robust active clinical experiments while having delved into twenty-five prior trials; all initiated from recording its inaugural investigation concerning such cases just around two decades ago (in early-2004).

These leading hospitals not only demonstrate unwavering commitment but serve as beacons of hope for those affected by glioblastoma. Their collaborative efforts highlight the tireless pursuit for advancements that hold potential life-changing impacts on patients' lives worldwide combating this formidable condition

Which are the best cities for glioblastoma clinical trials?

When it comes to glioblastoma clinical trials, several cities have emerged as prominent centers of research and innovation. New york, with 32 active trials, investigates treatments such as INO-5401, Pemigatinib, RT plus TMZ and ENZ among others. Boston follows closely behind with 29 ongoing studies focusing on therapies like Pembrolizumab and Olaparib. Saint Louis boasts 21 active trials examining interventions including Quality-of-Life Assessment and Radiation Therapy. Additionally, Los Angeles contributes significantly to the field with 18 ongoing trials exploring various treatment combinations involving RT plus TMZ and ENZ along with Adavosertib and Surgery approaches. Lastly, Dallas showcases its commitment to advancing care for glioblastoma patients through 16 active trials studying treatments like Pemigatinib and Sacituzumab Govitecan. These cities serve as beacons of hope for individuals battling this aggressive form of brain cancer by providing access to cutting-edge clinical trials that pave the way for improved outcomes in the future.

Which are the top treatments for glioblastoma being explored in clinical trials?

Glioblastoma, a formidable foe in the realm of brain cancers, is currently being tackled by cutting-edge treatments under exploration in clinical trials. Temozolomide emerges as a frontrunner with its involvement in six active trials and an impressive track record of 218 all-time glioblastoma studies since its debut in 2002. Nivolumab follows closely behind with three ongoing trials and 27 all-time glioblastoma investigations that began back in 2014. Additionally, radiation therapy commands attention with three active trials and a solid foundation of 48 all-time glioblastoma research efforts dating back to 2004. Two other contenders making strides include intra-arterial cetuximab and Ibrutinib, each involved in two active trials contributing to the limited but growing body of knowledge surrounding their potential effectiveness against this challenging cancer type.

What are the most recent clinical trials for glioblastoma?

Recent advancements in clinical trials offer hope for glioblastoma patients, with several promising studies underway. One such trial is examining the efficacy of autologous therapy in treating glioblastoma through a Phase 1 and Phase 2 Arm A approach. Another study focuses on Group A dose escalation as a potential treatment option for this aggressive brain tumor. Additionally, there are ongoing investigations into newly diagnosed glioblastoma participants to explore innovative therapies. With Stratum A trials and research on combining standard surgical treatment with intraoperative electrocorticography also making progress, these developments bring optimism to individuals battling glioblastoma.

What glioblastoma clinical trials were recently completed?

Numerous clinical trials for glioblastoma have recently concluded, showcasing the continuous efforts to combat this challenging brain cancer. In May 2021, Washington University School of Medicine completed a trial evaluating the potential of Tadalafil as a treatment option. Further back in January 2021, Kiarash Shahlaie, M.D., Ph.D., sponsored a Lidocaine trial that reached completion. Other notable studies include GLR2007 by Gan and Lee Pharmaceuticals in July 2020, Carboplatin by CarThera in February 2019, LB-100 by the National Cancer Institute (NCI) in January 2019, and Ribociclib by St. Joseph's Hospital and Medical Center in December 2018. These trials contribute valuable insights to advance our understanding of glioblastoma treatment options.